- Home
- AUPH vs SCSC Comparison
AUPH vs SCSC Comparison
Compare AUPH & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- SCSC
- Stock Information
- Founded
- AUPH 1993
- SCSC 1992
- Country
- AUPH Canada
- SCSC United States
- Employees
- AUPH N/A
- SCSC N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- SCSC Retail: Computer Software & Peripheral Equipment
- Sector
- AUPH Health Care
- SCSC Technology
- Exchange
- AUPH Nasdaq
- SCSC Nasdaq
- Market Cap
- AUPH 1.4B
- SCSC 892.3M
- IPO Year
- AUPH 1999
- SCSC 1994
- Fundamental
- Price
- AUPH $12.30
- SCSC $43.94
- Analyst Decision
- AUPH Strong Buy
- SCSC
- Analyst Count
- AUPH 3
- SCSC 0
- Target Price
- AUPH $12.00
- SCSC N/A
- AVG Volume (30 Days)
- AUPH 1.5M
- SCSC 313.6K
- Earning Date
- AUPH 11-06-2025
- SCSC 11-06-2025
- Dividend Yield
- AUPH N/A
- SCSC N/A
- EPS Growth
- AUPH N/A
- SCSC N/A
- EPS
- AUPH 0.42
- SCSC 3.00
- Revenue
- AUPH $260,111,000.00
- SCSC $3,040,810,000.00
- Revenue This Year
- AUPH $16.92
- SCSC $6.68
- Revenue Next Year
- AUPH $14.43
- SCSC $4.22
- P/E Ratio
- AUPH $29.12
- SCSC $14.92
- Revenue Growth
- AUPH 25.59
- SCSC N/A
- 52 Week Low
- AUPH $6.55
- SCSC $28.75
- 52 Week High
- AUPH $12.90
- SCSC $53.90
- Technical
- Relative Strength Index (RSI)
- AUPH 56.77
- SCSC 51.63
- Support Level
- AUPH $12.06
- SCSC $42.57
- Resistance Level
- AUPH $12.90
- SCSC $45.73
- Average True Range (ATR)
- AUPH 0.39
- SCSC 1.24
- MACD
- AUPH -0.08
- SCSC -0.06
- Stochastic Oscillator
- AUPH 54.89
- SCSC 37.23
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.